Literature DB >> 3154689

Risk factor intervention and prognosis after acute myocardial infarction.

G Lamm1.   

Abstract

The review is restricted to the three main risk factors of ischemic heart disease (IHD): cholesterol, blood pressure, and smoking. It deals with the question of whether these risk factors continue to affect prognosis after a first MI, without tackling the problem of how successful risk factor modification can be. Thus, neither primary nor secondary prevention trials are analyzed. The evidence from large, well conducted prospective studies shows that, although relative risk is greater prior to MI than thereafter, absolute risk is higher post-MI because of higher overall mortality. Although clinical characteristics and consequences of the acute event have a stronger prognostic power, it is still worthwhile to correct risk factors post-MI for a number of reasons.

Entities:  

Mesh:

Year:  1988        PMID: 3154689     DOI: 10.1007/bf00054264

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  8 in total

1.  Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

Authors:  M J Martin; S B Hulley; W S Browner; L H Kuller; D Wentworth
Journal:  Lancet       Date:  1986-10-25       Impact factor: 79.321

2.  The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the coronary drug project.

Authors:  R C Schlant; S Forman; J Stamler; P L Canner
Journal:  Circulation       Date:  1982-08       Impact factor: 29.690

3.  Long-term prognosis after recovery from myocardial infarction: a nine year follow-up of the Perth Coronary Register.

Authors:  C A Martin; P L Thompson; B K Armstrong; M S Hobbs; N de Klerk
Journal:  Circulation       Date:  1983-11       Impact factor: 29.690

4.  Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.

Authors:  J F Brensike; R I Levy; S F Kelsey; E R Passamani; J M Richardson; I K Loh; N J Stone; R F Aldrich; J W Battaglini; D J Moriarty
Journal:  Circulation       Date:  1984-02       Impact factor: 29.690

5.  Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomised controlled trial.

Authors:  R G Duffield; B Lewis; N E Miller; C W Jamieson; J N Brunt; A C Colchester
Journal:  Lancet       Date:  1983-09-17       Impact factor: 79.321

6.  Smoking and myocardial infarction.

Authors:  C Wilhelmsson; J A Vedin; D Elmfeldt; G Tibblin; L Wilhelmsen
Journal:  Lancet       Date:  1975-02-22       Impact factor: 79.321

7.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

Authors:  J Stamler; D Wentworth; J D Neaton
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

8.  Smoking and myocardial infarction: secondary prevention.

Authors:  J Perkins; T B Dick
Journal:  Postgrad Med J       Date:  1985-04       Impact factor: 2.401

  8 in total
  2 in total

1.  Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up.

Authors:  R B Singh; S S Rastogi; R Verma; B Laxmi; R Singh; S Ghosh; M A Niaz
Journal:  BMJ       Date:  1992-04-18

2.  Physical resilience after a diagnosis of cardiovascular disease among offspring of long-lived siblings.

Authors:  Angéline Galvin; Mary Feitosa; Konstantin Arbeev; Allison L Kuipers; Mary Wojczynski; Svetlana Ukrainsteva; Kaare Christensen
Journal:  Eur J Ageing       Date:  2021-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.